Late surgery for unilateral persistent fetal vasculature: long-term visual and anatomic outcomes

• Published in: Journal of AAPOS Vol. 26; no. 6; pp. 296.e1 - 296.e5
• Main Authors: Bata, Bashar M, Khalili, Sina, Ali, Asim, Wan, Michael J, Mireskandari, Kamiar
• Format: Journal Article
• Language: English
• Published: United States 01-12-2022
• Subjects: Follow-Up Studies; Humans; Infant; Persistent Hyperplastic Primary Vitreous - diagnosis; Persistent Hyperplastic Primary Vitreous - surgery; Postoperative Complications - surgery; Retrospective Studies; Visual Acuity; Vitrectomy
• ISSN: 1091-8531; 1528-3933
• DOI: 10.1016/j.jaapos.2022.09.005

Persistent fetal vasculature (PFV) is a congenital anomaly caused by failure of the ocular vasculature to regress. We report the visual and anatomic outcomes in patients who underwent surgery for PFV between 7-48 months of age.
The medical records of patients who underwent lensectomy and anterior or core vitrectomy for unilateral PFV, with or without intraocular lens implantation, were reviewed retrospectively. Inclusion criteria were surgery between 7-48 months of age and at least 12 months of follow-up. Patients with severe posterior segment involvement were excluded. The primary outcome was the final visual acuity using age-appropriate tests converted to logMAR. Secondary outcomes included the rate of adverse events and number of subsequent intraocular procedures.
A total of 20 patients with a mean age at surgery of 19.3 ± 10.5 months and mean follow-up of 73.7 ± 46.7 months were included. Sixteen patients had delayed surgery due to late presentation; the remaining 4 were managed initially with refractive correction and occlusion. Eight patients (40%) achieved a final visual acuity better than 1.0 logMAR. Four eyes had adverse events, including one retinal detachment. No patient developed glaucoma. Four eyes underwent subsequent procedures.
In our study cohort, surgery for unilateral PFV between 7-48 months of age achieved functional visual acuity in over one-third of patients. This is comparable to results achieved with surgery before 7 months of age, but with fewer adverse events. Differences in disease severity could account for later PFV presentation and surgery as well as outcomes.